Thalia Therapeutics - CEO Interview: Thalia’s RNA Therapeutics Strategy
Summary
We are pleased to share a conversation with our CEO, Dr David Solomon, offering insight into Thalia Therapeutic's vision, strategy, and opportunities ahead.
Your question will be sent privately to Thalia Therapeutics. The company may choose to make this question public.
Start the conversation
Ask Thalia Therapeutics a question about this announcement.
